# Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)

> **NCT01307371** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 110 (estimated)

## Conditions studied

- Left Ventricular Function Systolic Dysfunction
- Left Ventricular Function Diastolic Dysfunction
- Death
- Myocardial Reperfusion Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01307371
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2008-03
- **Final completion:** 2011-12
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01307371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01307371, "Cell Therapy in Diabetic Patients With ST-Segment Elevation Myocardial Infarction(STEMI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01307371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*